1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, August 2016 (p9)

Biological Therapy Analysis & Statistics, August 2016 (p9)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

241-270 of about 1100 reports

Purchase Reports From Reputable Market Research Publishers

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer
  • Countries : World
Osteoarthritis - Pipeline Review, H2 2016

Osteoarthritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline landscape. The report provides ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States, World
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016’, provides ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC ...

  • Industries : Therapy, Biopharmaceutical, Biotechnology, Pharmaceutical, Biological Therapy
  • Countries : United States
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N Sulphoglucosamine Sulphohydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, United States
Bronchopulmonary Dysplasia - Pipeline Review, H2 2016

Bronchopulmonary Dysplasia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Bronchopulmonary Dysplasia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bronchopulmonary Dysplasia - Pipeline Review, H2 2016’, provides an overview of the Bronchopulmonary Dysplasia ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

California Institute for Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary California Institute for Regenerative Medicine (CIRM) is a medical research service provider that makes grants and offers loans for stem cell research, facilities and other opportunities. The organization ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States
Biolife Solutions, Inc. (BLFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Biolife Solutions, Inc. (BLFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary BioLife Solutions, Inc. (BioLife Solutions) is a biotechnology company that offers generic products. The company designs, develops, manufactures, and markets biopreservation media products fo ...

  • Industries : Biological Therapy
Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Northwest Biotherapeutics, Inc. (NWBO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Northwest Biotherapeutics, Inc. (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated ...

  • Industries : Biological Therapy, Cancer, Pathology
Atara Biotherapeutics, Inc. (ATRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Atara Biotherapeutics, Inc. (ATRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Atara Biotherapeutics, Inc. (Atara) is a clinical-stage biopharmaceutical company that develops therapies for medical needs. The company develops drugs for muscle wasting conditions and cancer. ...

  • Industries : Biological Therapy
  • Countries : United States
Cell Therapy Catapult Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Therapy Catapult Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2016
  • by Global Data

Summary Cell Therapy Catapult Limited (Catapult), d/b/a Cell and Gene Therapy Catapult, is a biotechnology company that develops, delivers and commercializes cell and gene therapies. The company helps ...

  • Industries : Biological Therapy
  • Countries : United Kingdom
3D Cell Culture Market Analysis By Technology, By Application,, By End Use And Segment Forecasts To 2024

3D Cell Culture Market Analysis By Technology, By Application,, By End Use And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global 3D cell culture market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Global Cancer Therapeutics and Biotherapeutic Market Report 2016

Global Cancer Therapeutics and Biotherapeutic Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Cancer Therapeutics and Biotherapeutic Report is a professional and in-depth research report on the world's major regional market conditions of the Cancer Therapeutics and Biotherapeutic industry, ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by Global Data

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Mental Health, Pharmaceutical, Pathology
  • Countries : World
Cell Therapy - Industry Market Research Report

Cell Therapy - Industry Market Research Report

  • $ 1020
  • Industry report
  • August 2016
  • by Ibisworld

Generating growth: More funding for R&D will spur strong revenue gains Cell Therapy Although the Cell Therapy industry is a fast-growing industry, its companies operate at a loss due to the high costs ...

  • Industries : Biological Therapy
  • Countries : United States
Global Therapeutic Vaccines Market Report 2016

Global Therapeutic Vaccines Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Therapeutic Vaccines Report is a professional and in-depth research report on the world's major regional market conditions of the Therapeutic Vaccines industry, focusing on the main regions ...

  • Industries : Biological Therapy, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World, Europe, Asia, North America
Global Cell Line Toxicology Instruments Market Research Report 2016

Global Cell Line Toxicology Instruments Market Research Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Cell Line Toxicology Instruments Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Cell Line Toxicology Instruments industry, ...

  • Industries : Biological Therapy, General Medicine and Specialty Medicine
  • Countries : World, Europe, Asia, North America
T-Cell Immunotherapy for Cancer -  Pipeline Analysis

T-Cell Immunotherapy for Cancer - Pipeline Analysis

  • $ 1500
  • Industry report
  • August 2016
  • by RNCOS

Cancer is a leading cause of death worldwide. According to GLOBOCAN 2012, the incidence of cancer is expected to increase from 14 Million in 2012 to approximately 21 Million by 2030. Although conventional ...

  • Industries : Biological Therapy
  • Countries : World
CytoSorbents Corporation (CTSO) - Product Pipeline Analysis, 2016 Update

CytoSorbents Corporation (CTSO) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • August 2016
  • by Global Data

Summary CytoSorbents Corporation (CytoSorbents), formerly MedaSorb Technologies Corporation is a medical device company that designs and develops blood purification technology. The company develops adsorbent ...

  • Industries : General Medicine and Specialty Medicine
  • Countries : United States, Russian Federation
Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2016 Update

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • August 2016
  • by Global Data

Summary Rosetta Genomics Ltd (RGL) is a biotechnology company that develops next generation diagnostic tests for personalized medicine. The company offers testing services such as cancer origin, next-gen, ...

  • Industries : Genomics, Cancer
  • Countries : United States
Crohn%s Disease (Regional Enteritis) - Pipeline Review, H2 2016

Crohn%s Disease (Regional Enteritis) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Genital Herpes - Pipeline Review, H2 2016

Genital Herpes - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Genital Herpes - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H2 2016’, provides an overview of the Genital Herpes pipeline landscape. The report provides ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : United States
Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016’, ...

  • Industries : Biological Therapy, Pharmaceutical, Therapy, Drug Discovery and Development
  • Countries : United States, World
Epstein-Barr Viral Infections - Pipeline Review, H2 2016

Epstein-Barr Viral Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2016’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Therapy, Cancer, Pharmaceutical, Biotechnology
  • Countries : United States, World, United Kingdom
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016’, provides an overview ...

  • Industries : Cancer, Pathology, Biological Therapy, Biotechnology
  • Countries : United States
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016’, provides an overview of the B-Cell ...

  • Industries : Cancer, Pathology
  • Countries : United States
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

  • $ 1023
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 102 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 168 specific intracellular signaling pathways ...

  • Industries : Biological Therapy
Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

REPORT DESCRIPTION This report analyzes the current and future prospects of the regenerative medicine across the globe. Regenerative medicine is considered as an emerging field of medical science that ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World
Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

3D cell culture is a man-made environment which is created to allow cells to grow and interact with the surroundings in all three dimensions. It is an advanced cell culture technique that overcomes limitations ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World
Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • $ 4740
  • Industry report
  • August 2016
  • by Allied Market Research

Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring ...

  • Industries : Biological Therapy
  • Countries : World
About 2800 reports

Download Unlimited Documents from Trusted Public Sources

Medigene AG - Investor Report, December 2016

  • December 2016
    39 pages
  • Immunotherapy  

    Cell Therapy  

  • Germany  

View report >

Filgrastim Industry

December 2016

Microrna Industry

November 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.